NFKB1 and pulmonary fibrosis: Taken together, scutellarin delivered anti-inflammatory efficacy in pulmonary fibrosis through inhibiting BLM-induced NF-κB/NLRP3 signaling, and overexpression of NLRP3 partly eliminated the function of scutellarin.